Public Health & Epidemiology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Recommendations, most recent by
Eivind Berge, Oslo University Hospital, Norway. F1000 Cardiovascular Disorders
- Clinical Trial
- Clinical Trial: RCT
- Confirmation
- Good for Teaching
Past 7 Days
25
New Recommendations
8,514 total
14
New Articles Recommended
5,702 total
Past 30 Days
-
19Articles Classified As Controversial747 total
-
1Articles Classified As Novel Drug Target9 total
-
10Articles Classified As Review / Commentary622 total
-
46Articles Classified As Confirmation2,734 total
-
2Articles Classified As Technical Advance381 total
-
61Articles Classified As New Finding3,366 total
-
17Articles Classified As Interesting Hypothesis1,248 total
-
44Articles Classified As Good for Teaching354 total
-
5Articles Classified As Refutation171 total
-
22Articles Classified As Clinical Trial1,553 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

